Abstract:Alicja Hinz, 1 Marta Szczęch, 2 Krzysztof Szczepanowicz, 2 Monika Bzowska 1 1 Department of Cell Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland; 2 Jerzy Haber Institute of Catalysis and Surface Chemistry Polish Academy of Sciences, Kraków, Poland Correspondence: Monika Bzowska Department of Cell Biochemistry, Faculty of Biochemistry, Jagiellonian University in Kraków, Biophysics and Biotechnology, 7 Gronostajowa Street, Kraków, 30-387, Poland, Tel/Fax +48 12 664 63 88, Email Krzysztof Szczepanowicz Jerzy Haber Institute of Catalysis and Surface Chemistry Polish Academy of Sciences, Niezapominajek 8 Street, Kraków, 30-239, Poland, Tel/Fax +48 12 639 51 21, Email Introduction: Biodistribution of nanocarriers with a structure consisting of core and shell is most often analyzed using methods based on labeling subsequent compartments of nanocarriers. This approach may have serious limitations due to the instability of such complex systems under in vivo conditions. Methods: The core-shell polyelectrolyte nanocarriers were intravenously administered to healthy BALB/c mice with breast cancer. Next, biodistribution profiles and elimination routes were determined post mortem based on fluorescence measurements performed for isolated blood, tissue homogenates, collected urine, and feces. Results: Despite the surface PEGylation with PLL-g-PEG, multilayer polyelectrolyte nanocarriers undergo rapid degradation after intravenous administration. This process releases the shell components but not free Rhodamine B. Elements of polyelectrolyte shells are removed by hepatobiliary and renal clearance. Conclusion: Multilayer polyelectrolyte nanocarriers are prone to rapid degradation after intravenous administration. Fluorophore localization determines the obtained results of biodistribution and elimination routes of core-shell nanomaterials. Therefore, precise and reliable analysis of in vivo stability and biodistribution of nanomaterials composed of several compartments requires nanomaterials labeled within each compartment. Keywords: in vivo studies, fluorescently labeled nanomaterials, stealth polymers, pharmacokinetics, routes of elimination, nanocarriers stability and degradation Evaluation of nanomaterial pharmacokinetics, biodistribution, and clearance is essential in preclinical studies of all nanomedicines, regardless of their route of administration and proposed use. Determining the half-life of nanoparticles in the serum, the degree of their accumulation in organs, and elimination routes allows predicting tissues exposed to the potentially toxic nanocarriers and verify nanoparticles retention in the diseased tissues. Moreover, the analysis of pharmacokinetics, especially in serum, provides indirect information on the stability of nanoparticles since the short half-life in serum often results from premature nanomaterial breakdown in the bloodstream immediately after administration. 1 The pharmacokinetics and biodistribution of nanocarriers are determined primarily by their chemical structure, physical properties, the administration route, and the unique biological properties of tissues that, after administration, have direct contact with nanomaterials. 2 For example, Enhance Permeability and Retention phenomenon (EPR) allows the accumulation of nanomaterials in these tumors characterized by blood vessels with increased permeability and reduced lymphatic drainage. 3 Analysis of the nanomaterial retention in tissues or body fluids often involves measurements of the active agent concentration transported by the nanocarriers (eg anti-cancer drug). 4 Another approach requires labeling nanomaterials with various isotopes, fluorophores, or metals. Pharmacokinetics and biodistribution are then determined using radiation or fluorescence measurements, magnetic resonance imaging, or computed tomography. To further complicate, the signal may be detected either intravitally or postmortem. 5 In the case of intravital imaging, anesthesia is required, which may influence the results of pharmacokinetic analysis (anesthesia lowers, eg the cardiac index). 6 The molecules employed for nanomaterial labeling are attached within the nanoparticle by covalent bonds, electrostatic interactions, or immobilized in the nanomaterial compartment to which they have increased affinity (eg hydrophilic molecules inside liposomes). Additionally, some nanocarriers are made of more than one compartment (eg core-shell nanoparticles); thus, the label may be located in a different part of the nanoparticle. Nanomaterials of this type can be made of organic and inorganic components, -Abstract Truncated-

Biodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP)

Preparation and Preliminary Molecular Imaging Study of 124I In-Situ Labeled Organic Melanin Nanoparticles

Development of Small HN Linked Radionuclide Iodine-125 for Nanocarrier Image Tracing in Mouse Model

Application Analysis of 124I-PPMN for Enhanced Retention in Tumors of Prostate Cancer Xenograft Mice.

Pharmacokinetics and Biodistribution of Near-Infrared Fluorescence Polymeric Nanoparticles

Radiolabeled multi-layered coated gold nanoparticles, as potential biocompatible PET/SPECT tracers

Highly Effective Radioisotope Cancer Therapy with a Non-Therapeutic Isotope Delivered and Sensitized by Nanoscale Coordination Polymers

A Novel, Chelator-Free Method for 64cu Labeling of Dendrimers

Fluorophore Localization Determines the Results of Biodistribution of Core-Shell Nanocarriers

Use of a clinical PET/CT scanner for whole body biodistribution of intranasal nanoparticles

Design and Modular Construction of a Polymeric Nanoparticle for Targeted Atherosclerosis Positron Emission Tomography Imaging: A Story of 25% (64)Cu-CANF-Comb

Design and Synthesis of 111In-Ccpm-rgd Nanoparticles for Dual-modality Molecular Imaging

Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging

Polyphosphoric acid capping radioactive/upconverting NaLuF4: Yb,Tm,153Sm nanoparticles for blood pool imaging invivo

Iodine-Labeled Au Nanorods with High Radiochemical Stability for Imaging-Guided Radiotherapy and Photothermal Therapy

68Ga-labeled amphiphilic polymer nanoparticles for PET imaging of sentinel lymph node metastasis

Tracing Boron with Fluorescence and Positron Emission Tomography Imaging of Boronated Porphyrin Nanocomplex for Imaging-Guided Boron Neutron Capture Therapy

Visualisation of Dual Radiolabelled Poly(lactide-Co-glycolide) Nanoparticle Degradation in Vivo Using Energy-Discriminant SPECT.

Biocompatible Conjugated Polymer Nanoparticles Labeled with 225 Ac for Tumor Endoradiotherapy

64Cu radiolabeled nanomaterials for positron emission tomography (PET) imaging

In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation